US 10513557
Anti-ASIC1 antibodies and uses thereof
granted A61KA61K2039/505A61K39/00
Quick answer
US patent 10513557 (Anti-ASIC1 antibodies and uses thereof) held by REGENERON PHARMACEUTICALS, INC. expires Mon Dec 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Dec 24 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 27
- CPC classes
- A61K, A61K2039/505, A61K39/00, A61P, A61P25/04